Glutamatergic Gene Expression Is Specifically Reduced in Thalamocortical Projecting Relay Neurons in Schizophrenia

BACKGROUND Impairment of glutamate neurons that relay sensory and cognitive information from the medial dorsal thalamus to the dorsolateral prefrontal cortex and other cortical regions may contribute to the pathophysiology of schizophrenia. In this study, we have assessed the cell-specific expression of glutamatergic transcripts in the medial dorsal thalamus. METHODS We used laser capture microdissection to harvest two populations of medial dorsal thalamic cells, one enriched with glutamatergic relay neurons and the other with gamma-aminobutyric acidergic neurons and astroglia, from postmortem brains of subjects with schizophrenia (n = 14) and a comparison group (n = 20). Quantitative polymerase chain reaction of extracted RNA was used to assay gene expression in the different cell populations. RESULTS The transcripts encoding the ionotropic glutamate receptor subunits NR2D, GluR3, GluR6, GluR7, and the intracellular proteins GRIP1 and SynGAP1 were significantly decreased in relay neurons but not in the mixed glial and interneuron population in schizophrenia. CONCLUSIONS Our data suggest that reduced ionotropic glutamatergic expression occurs selectively in neurons, which give rise to the cortical projections of the medial dorsal thalamus in schizophrenia, rather than in thalamic cells that function locally. Our findings indicate that glutamatergic innervation is dysfunctional in the circuitry between the medial dorsal thalamus and cortex.

[1]  D J Healy,et al.  Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. , 2000, The American journal of psychiatry.

[2]  J. Meador-Woodruff,et al.  Role of glutamate in schizophrenia: integrating excitatory avenues of research , 2008, Expert review of neurotherapeutics.

[3]  D. German,et al.  Elevated neuron number in the limbic thalamus in major depression. , 2004, The American journal of psychiatry.

[4]  Paul J. Harrison,et al.  GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT-PCR) study. , 1997, Brain research. Molecular brain research.

[5]  Nicolette Marshall,et al.  Magnetic resonance imaging of the thalamus and adhesio interthalamica in twins with schizophrenia. , 2007, Archives of general psychiatry.

[6]  V. Haroutunian,et al.  Up‐regulation of NMDA receptor subunit and post‐synaptic density protein expression in the thalamus of elderly patients with schizophrenia , 2006, Journal of neurochemistry.

[7]  Paul J. Harrison,et al.  Glutamate Receptors and Transporters in the Hippocampus in Schizophrenia , 2003, Annals of the New York Academy of Sciences.

[8]  J. Olney,et al.  Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.

[9]  B. Pakkenberg,et al.  Schizophrenia; from structure to function with special focus on the mediodorsal thalamic prefrontal loop , 2009, Acta psychiatrica Scandinavica.

[10]  J. Noga,et al.  Further postmortem autoradiographic studies of AMPA receptor binding in schizophrenia , 2002, Synapse.

[11]  J. Corwin,et al.  Effects of d-cycloserine on negative symptoms in schizophrenia , 2004, Schizophrenia Research.

[12]  P. Ward,et al.  Selective Alterations in Ionotropic Glutamate Receptors in the Anterior Cingulate Cortex in Schizophrenia , 2002, Neuropsychopharmacology.

[13]  Edward G Jones,et al.  Vesicular glutamate transporters define two sets of glutamatergic afferents to the somatosensory thalamus and two thalamocortical projections in the mouse , 2008, The Journal of comparative neurology.

[14]  V. Vingtdeux,et al.  Calcium signaling in neurodegeneration , 2009, Molecular Neurodegeneration.

[15]  B. Sokolov,et al.  Expression of NMDAR1, GluR1, GluR7, and KA1 Glutamate Receptor mRNAs Is Decreased in Frontal Cortex of “Neuroleptic‐Free” Schizophrenics: Evidence on Reversible Up‐Regulation by Typical Neuroleptics , 1998, Journal of neurochemistry.

[16]  D. Javitt,et al.  Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. , 1987, The Hillside journal of clinical psychiatry.

[17]  G. Rosenbaum,et al.  Study of a new schizophrenomimetic drug; sernyl. , 1959, A.M.A. archives of neurology and psychiatry.

[18]  R W Neufeld,et al.  Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. , 1997, Archives of general psychiatry.

[19]  J. Meador-Woodruff,et al.  Abnormal Glutamate Receptor Expression in the Medial Temporal Lobe in Schizophrenia and Mood Disorders , 2007, Neuropsychopharmacology.

[20]  Ravi S. Menon,et al.  Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. , 2003, The American journal of psychiatry.

[21]  Richard A. Komoroski,et al.  In vitro 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia , 1997, Biological Psychiatry.

[22]  C. Houser,et al.  Two Forms of the γ‐Aminobutyric Acid Synthetic Enzyme Glutamate Decarboxylase Have Distinct Intraneuronal Distributions and Cofactor Interactions , 1991, Journal of neurochemistry.

[23]  F. Fumagalli,et al.  Chronic phencyclidine administration reduces the expression and editing of specific glutamate receptors in rat prefrontal cortex , 2007, Experimental Neurology.

[24]  R Freedman,et al.  Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. , 2005, Brain research. Molecular brain research.

[25]  D. German,et al.  Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia , 2000, Biological Psychiatry.

[26]  E. G. Jones,et al.  Distribution of tachykinin- and enkephalin-immunoreactive fibers in the human thalamus , 1989, Brain Research Reviews.

[27]  E. Jones Functional subdivision and synaptic organization of the mammalian thalamus. , 1981, International review of physiology.

[28]  T. Kuner,et al.  Multiple Structural Elements Determine Subunit Specificity of Mg2+ Block in NMDA Receptor Channels , 1996, The Journal of Neuroscience.

[29]  Marc G Caron,et al.  Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia , 1999, Cell.

[30]  Thomas Ragg,et al.  The RIN: an RNA integrity number for assigning integrity values to RNA measurements , 2006, BMC Molecular Biology.

[31]  F. Benes,et al.  Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. , 1992, Cerebral cortex.

[32]  P. McKenna,et al.  Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus. , 2000, Brain research. Molecular brain research.

[33]  F. Goodwin,et al.  Brain endolases as specific markers of neuronal and glial cells. , 1978, Science.

[34]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[35]  Carol A. Tamminga,et al.  Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia , 1995, Neuropsychopharmacology.

[36]  J. Meador-Woodruff,et al.  Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities , 2004, Schizophrenia Research.

[37]  D. Lodge The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature , 2009, Neuropharmacology.

[38]  C. McBain,et al.  N-methyl-D-aspartic acid receptor structure and function. , 1994, Physiological reviews.

[39]  V. Haroutunian,et al.  N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. , 2001, The American journal of psychiatry.

[40]  J. Meador-Woodruff,et al.  Abnormalities of the NMDA Receptor and Associated Intracellular Molecules in the Thalamus in Schizophrenia and Bipolar Disorder , 2004, Neuropsychopharmacology.

[41]  R. Conley,et al.  Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. , 2000, The American journal of psychiatry.

[42]  K. Newell,et al.  Ionotropic glutamate receptor binding in the posterior cingulate cortex in schizophrenia patients , 2005, Neuroreport.

[43]  Mary B. Kennedy,et al.  Spine architecture and synaptic plasticity , 2005, Trends in Neurosciences.

[44]  石丸 昌彦 Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics : evidence for glutamate hypothesis , 1994 .

[45]  R. Huganir,et al.  SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Lajtha,et al.  Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: Is selective loss of glutamatergic neurons associated with major psychoses? , 1993, Neurochemical Research.

[47]  M. Burset,et al.  Multiplex preamplification of specific cDNA targets prior to gene expression analysis by TaqMan Arrays , 2008, BMC Research Notes.

[48]  A. Erisir,et al.  VGluT2 immunochemistry identifies thalamocortical terminals in layer 4 of adult and developing visual cortex , 2005, The Journal of comparative neurology.

[49]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[50]  J. Coyle,et al.  The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. , 2001, The American journal of psychiatry.

[51]  K. Davis,et al.  Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. , 1998, Archives of general psychiatry.

[52]  Paul J. Harrison,et al.  Immunoautoradiographic evidence for a loss of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia , 1997, Biological Psychiatry.

[53]  C. Breese,et al.  Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers , 1995, Brain Research.

[54]  J. Pierri,et al.  Altered Cortical Glutamate Neurotransmission in Schizophrenia , 2003 .

[55]  E G Jones,et al.  Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[56]  K. Sim,et al.  Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review , 2008, Journal of Neural Transmission.

[57]  M. Toru,et al.  Increases in strychnine-insensiive glycine binding sites in cerebral cortex of chronic schizophrenics: Evidence for glutamate hypothesis , 1994, Biological Psychiatry.

[58]  Mary B. Kennedy,et al.  The postsynaptic density at glutamatergic synapses , 1997, Trends in Neurosciences.

[59]  J. Meador-Woodruff,et al.  Glutamate receptor expression in schizophrenic brain , 2000, Brain Research Reviews.

[60]  J. Trojanowski,et al.  Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. , 2002, Archives of general psychiatry.

[61]  E G Jones,et al.  Cortical development and thalamic pathology in schizophrenia. , 1997, Schizophrenia bulletin.

[62]  S. Hirsch,et al.  NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia. , 1996, Neuroreport.

[63]  J. Meador-Woodruff,et al.  Molecular Abnormalities of the Glutamate Synapse in the Thalamus in Schizophrenia , 2003, Annals of the New York Academy of Sciences.

[64]  Bert Sakmann,et al.  Heteromeric NMDA Receptors: Molecular and Functional Distinction of Subtypes , 1992, Science.

[65]  T. Nabeshima,et al.  Animal Model of Schizophrenia , 2006, Annals of the New York Academy of Sciences.

[66]  G. Rosenbaum,et al.  Comparison of sernyl with other drugs: simulation of schizophrenic performance with sernyl, LSD-25, and amobarbital (amytal) sodium; I. Attention, motor function, and proprioception. , 1959, A.M.A. archives of general psychiatry.

[67]  G. Rosenbaum,et al.  Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Simulation of schizophrenic performance with phencyclidine hydrochloride (Sernyl), lysergic acid diethylamide (LSD-25), and amobarbital (Amytal) sodium; II. Symbolic and sequential thinking. , 1962, Archives of general psychiatry.

[68]  N. Farber The NMDA Receptor Hypofunction Model of Psychosis , 2003, Annals of the New York Academy of Sciences.

[69]  L. Crepaldi,et al.  Altered Dimerization of Metabotropic Glutamate Receptor 3 in Schizophrenia , 2007, Biological Psychiatry.

[70]  J. Walecki,et al.  The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS). , 2005, Pharmacopsychiatry.

[71]  William Byne,et al.  Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. , 2002, The American journal of psychiatry.

[72]  J. Pierri,et al.  Altered cortical glutamate neurotransmission in schizophrenia: evidence from morphological studies of pyramidal neurons. , 2003, Annals of the New York Academy of Sciences.

[73]  D. Javitt,et al.  Neurophysiological and neurochemical animal models of schizophrenia: Focus on glutamate , 2009, Behavioural Brain Research.

[74]  William Byne,et al.  Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia. , 2003, Archives of general psychiatry.

[75]  B. Dean,et al.  Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder , 2007, Brain Research.

[76]  E. Bullmore,et al.  The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. , 2008, The American journal of psychiatry.

[77]  A. Sampson,et al.  Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: Volume, neuron number, and cell types , 2004, The Journal of comparative neurology.

[78]  Ravi S. Menon,et al.  Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. , 2002, The American journal of psychiatry.

[79]  Paul J. Harrison,et al.  A postmortem study of the mediodorsal nucleus of the thalamus in schizophrenia , 2003, Schizophrenia Research.

[80]  Joseph T. Coyle,et al.  The Glutamatergic Dysfunction Hypothesis for Schizophrenia , 1996, Harvard review of psychiatry.

[81]  V. Haroutunian,et al.  mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics , 2005, Journal of neuroscience research.

[82]  V. Haroutunian,et al.  Ionotropic glutamate receptor mRNA expression in the human thalamus: Absence of change in schizophrenia , 2008, Brain Research.

[83]  R. Huganir,et al.  Persistent hippocampal CA1 LTP in mice lacking the C-terminal PDZ ligand of GluR1 , 2005, Nature Neuroscience.

[84]  G. Collingridge,et al.  NMDA receptor dependence of mGlu‐mediated depression of synaptic transmission in the CA1 region of the rat hippocampus , 1996, British journal of pharmacology.

[85]  J. Meador-Woodruff,et al.  Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression , 2005, Schizophrenia Research.

[86]  Jones Eg Functional subdivision and synaptic organization of the mammalian thalamus. , 1981 .

[87]  K. Davis,et al.  Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus , 2000, Biological Psychiatry.

[88]  P. Slater,et al.  Frontal Cortical and Left Temporal Glutamatergic Dysfunction in Schizophrenia , 1989, Journal of neurochemistry.

[89]  K. Davis,et al.  Abnormal Kainate Receptor Expression in Prefrontal Cortex in Schizophrenia , 2001, Neuropsychopharmacology.

[90]  F. Benes,et al.  GluR5,6,7 subunit immunoreactivity on apical pyramidal cell dendrites in hippocampus of schizophrenics and manic depressives , 2001, Hippocampus.

[91]  L. Lapham,et al.  Immunofluorescence staining of astrocytes in vitro using antiserum to glial fibrillary acidic protein , 1975, Brain Research.

[92]  K. Davis,et al.  Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia , 2005, Synapse.